Lisa Wang Selected Research

Immunotherapy

1/2022	Translational randomized phase II trial of cabozantinib in combination with nivolumab in advanced, recurrent, or metastatic endometrial cancer.
1/2022	Systematic pan-cancer analysis of mutation-treatment interactions using large real-world clinicogenomics data.
1/2021	Applications of Circulating Tumor DNA in a Cohort of Phase I Solid Tumor Patients Treated With Immunotherapy.
1/2019	Hyperprogressive disease in early-phase immunotherapy trials: Clinical predictors and association with immune-related toxicities.
12/2018	Association of Ipilimumab With Safety and Antitumor Activity in Women With Metastatic or Recurrent Human Papillomavirus-Related Cervical Carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lisa Wang Research Topics

Disease

48	Neoplasms (Cancer) 03/2024 - 01/2006
9	Ovarian Neoplasms (Ovarian Cancer) 11/2022 - 03/2006
8	Fatigue 11/2022 - 10/2011
8	Ovarian Epithelial Carcinoma 11/2022 - 06/2010
8	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 05/2005
7	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 12/2010
6	Diarrhea 01/2023 - 10/2016
6	Hypertension (High Blood Pressure) 05/2022 - 01/2010
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 11/2008
5	Disease Progression 01/2022 - 04/2008
5	Neoplasm Metastasis (Metastasis) 01/2021 - 06/2013
4	Carcinoma (Carcinomatosis) 03/2024 - 06/2012
4	Endometrial Neoplasms (Endometrial Cancer) 01/2023 - 08/2014
4	Adenocarcinoma 12/2022 - 06/2012
4	Hepatocellular Carcinoma (Hepatoma) 06/2022 - 04/2004
4	Breast Neoplasms (Breast Cancer) 09/2020 - 01/2010
4	Squamous Cell Carcinoma of Head and Neck 10/2016 - 02/2011
3	Neutropenia 01/2021 - 01/2010
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2019 - 04/2008
3	Hemorrhage 01/2017 - 01/2007
3	Ascites 07/2010 - 03/2006
2	Thrombocytopenia (Thrombopenia) 01/2023 - 01/2021
2	Carcinosarcoma 01/2022 - 08/2014
2	Pain (Aches) 11/2020 - 10/2014
2	Melanoma (Melanoma, Malignant) 05/2019 - 04/2016
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2019 - 12/2018
2	Infections 10/2017 - 02/2011
2	Hypoxia (Hypoxemia) 01/2017 - 06/2012
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2016 - 06/2012
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2016 - 09/2011
2	Mucositis 10/2013 - 07/2012
2	Anemia 10/2013 - 06/2012
2	Lymphoma (Lymphomas) 03/2011 - 05/2009
2	Brain Neoplasms (Brain Tumor) 11/2009 - 04/2007
2	Peritoneal Neoplasms 03/2006 - 05/2005
1	Cataract (Cataracts) 11/2023
1	COVID-19 01/2023
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2023
1	Uterine Neoplasms (Uterine Cancer) 01/2023
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 11/2022

Drug/Important Bio-Agent (IBA)

9	PlatinumIBA 11/2022 - 11/2009
7	Gemcitabine FDA Link 11/2022 - 07/2010
6	Proteins (Proteins, Gene)FDA Link 03/2024 - 01/2006
6	Sorafenib (BAY 43-9006)FDA Link 01/2017 - 04/2008
5	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 04/2011
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 03/2006
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 04/2014
4	ErbB Receptors (EGF Receptor)IBA 01/2022 - 03/2010
4	Bevacizumab (Avastin)FDA Link 01/2021 - 11/2009
4	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 10/2016
4	Sunitinib (Sutent)FDA Link 01/2019 - 08/2014
4	Docetaxel (Taxotere)FDA Link 01/2019 - 04/2011
4	Drug CombinationsIBA 10/2013 - 04/2007
4	Messenger RNA (mRNA)IBA 01/2013 - 01/2006
4	Albendazole (Albenza)FDA Link 07/2010 - 05/2005
3	adavosertibIBA 01/2023 - 01/2021
3	trametinibIBA 12/2022 - 12/2021
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2022 - 12/2021
3	cabozantinibIBA 06/2022 - 01/2020
3	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2019
3	Paclitaxel (Taxol)FDA LinkGeneric 11/2020 - 09/2010
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 04/2016 - 01/2010
3	cediranib (AZD2171)IBA 04/2016 - 08/2013
3	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 05/2015 - 10/2013
3	2,2- dimethyl- N- (6- oxo- 6,7- dihydro- 5H- dibenzo(b,d)azepin- 7- yl)- N'- (2,2,3,3,3- pentafluoropropyl)malonamideIBA 05/2015 - 10/2013
3	Vorinostat FDA Link 01/2015 - 05/2009
3	Decitabine FDA Link 01/2015 - 05/2009
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 06/2012 - 11/2009
2	Phosphotransferases (Kinase)IBA 01/2023 - 06/2012
2	CreatinineIBA 01/2023 - 06/2011
2	Tyrosine Kinase InhibitorsIBA 01/2022 - 12/2010
2	EnzymesIBA 01/2022 - 01/2007
2	Cetuximab (Erbitux)FDA Link 01/2022 - 10/2016
2	Alanine Transaminase (SGPT)IBA 01/2022 - 04/2015
2	VaccinesIBA 11/2020 - 03/2011
2	Cytokine Receptors (Cytokine Receptor)IBA 01/2020 - 10/2007
2	Pantoprazole (Protonix)FDA LinkGeneric 01/2019 - 12/2014
2	dacomitinibIBA 10/2017 - 10/2016
2	pazopanib FDA Link 04/2015 - 01/2010
2	Capecitabine (Xeloda)FDA Link 08/2014 - 05/2012
2	saracatinibIBA 01/2014 - 06/2012
2	src-Family KinasesIBA 01/2014 - 06/2012
2	Antineoplastic Agents (Antineoplastics)IBA 01/2011 - 04/2007
1	Immunoconjugates (Immunoconjugate)IBA 03/2024
1	Anaphase-Promoting Complex-Cyclosome Apc1 SubunitIBA 11/2023
1	selinexorIBA 10/2023
1	Androgen Receptors (Androgen Receptor)IBA 10/2023
1	niraparibIBA 01/2023
1	dostarlimabIBA 01/2023
1	Indicators and Reagents (Reagents)IBA 01/2023
1	GSK2256098IBA 12/2022
1	AZD 6244IBA 11/2022
1	SmokeIBA 05/2022

Therapy/Procedure

22	Drug Therapy (Chemotherapy) 03/2024 - 11/2009
21	Therapeutics 03/2024 - 01/2007
12	Radiotherapy 01/2023 - 04/2011
6	Castration 01/2021 - 04/2011
5	Immunotherapy 01/2022 - 12/2018
2	Adjuvant Radiotherapy 09/2020 - 01/2016
1	Liver Transplantation 06/2022